PlainRecalls
FDA Drug Low Class III Terminated

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534

Reported: December 28, 2016 Initiated: November 2, 2016 #D-0207-2017

Product Description

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534

Reason for Recall

Failed Dissolution Specifications; 6 month time point

Details

Units Affected
16,356 bottles
Distribution
Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 16,356 bottles.
Why was this product recalled?
Failed Dissolution Specifications; 6 month time point
Which agency issued this recall?
This recall was issued by the FDA Drug on December 28, 2016. Severity: Low. Recall number: D-0207-2017.